Mitomycin С is an antibiotic obtained from natural sources, mechanism of action is related to the formation of cross-links with DNA that prevents the action of helicase and consequently cell proliferation. Mitomycin is given intravenously, intravesically, intraperitoneally, also can be used topically to treat or prevent scarring in the postoperative period, in particular urethral strictures. Mitomycin C has anti-fibroblastic properties and prevents the collagen formation in tissues. However, it is known that a wide range of antibiotics and cytostatics can also cause oxidative stress. And lipid peroxidation is the universal mechanism of cell membrane damage in various pathologies. The gluthatione antiperoxide system plays a leading role in the disposal of secondary peroxidation products and other oxidized substances. Lymphocytes are the heterogeneous cell population and a central link in specific immune response, they rapidly respond to oxidative stress and according to various research studies, activity of antioxidant enzyme defense system can serve as a marker for pathological conditions and adaptive mechanisms. Based on this, the purpose of this research, which was conducted on peripheral blood lymphocytes, was to elucidate the link between the action of mitomycin C and the state of pro-/ antioxidant system. We conducted a comparative study of the action of mitomycin C on the lipid peroxidation process and glutathione system in peripheral blood lymphocytes. The growth of lipid peroxidation process with action of different mitomycin concentrations has been shown, which was evaluated by determining the malonic dialdehyde concentrations. Under the action of mitomycin C glutathione peroxidase activity dose-dependently increases at all its concentrations and reaches its highest value at 10 -3 М concentration, however, reduced glutathione concetration at drug concentrations of 10 -6 –10 -4 М does not change concerning control values. Glutathione reductase activity reliably increases under the action of mitomycin C at 10 -6 М and 10 -5 М concentrations and reliably reduces at higher concentrations (10 -3 М). At all investigated mitomycin C concentrations glutathione-S-transferase activity reduces reliably and dose-dependently. Thus, in addition to the main mechanism of action of mitomycin C that is the formation of cross-links with DNA, inhibition of fibroblast proliferation and prevention of postoperative scarring, this drug significantly affects pro-/ antioxidant status of blood lymphocytes.

Received: 18.04.2022

Ключові слова: Mitomycin C, lymphocytes, oxidative stress, lipid peroxidation, glutathione system

Повний текст: PDF (Ukr)

1. 1. Jamieson D. Mitimicyn C. In book: Encyclopedia of Cancer. 2014:2879-2883.
2. 2. Park JJ, Kuo TL, Chapple CR. Mitomycin C in the treatment of anterior urethral strictures. Nature Reviews Urology. 2018;15:717-718.
3. 3. Verweij J, Pineto HM. Mitomycin C: mechanism of action, usefulness and limitations. Anti-Cancer Drugs. 1990;1:5-13.
4. 4. Alyaev YuG, Rapoport LM, Tsarichenko DG, Artemov AV. Application of mitomycin in the treatment of cicatricial complications after radical prostatectomy Andrology and Genital Surgery. 23014;14(2):19:25.
5. 5. Hampson LA, McAninch JW, Breyer BN. Male urethral strictures and their management. Urology. 2014;11:43-50.
6. 6. Kuo TL, Venugopa S, Inman RD et al . Surgical tips and tricks during urethroplasty for bulbar urethral strictures focusing on accurate localisation of the stricture: results from a tertiary centre. Eur Urol. 2015;67(4):764-770.
7. 7. Kurt O, Gevher F, Yazic CM et al. Effect of mitomycin - C and triamcinolone on preventing urethral strictures. Int Braz J Urol. 2017;43(5):939-945.
8. 8. Mazdak H, Izadpanahi MH, Ghalamkari A et al. Internal urethrotomy and intraurethral submucosal injection of triamcinolone in short bulbar urethral strictures. Int Urol Nephrol. 2010;42(3):565-568. doi: 10.1007/s11255-009-9663-5.
9. 9. Mazdak H, Meshki I, Ghassami F. Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. Eur Urol. 2007;51(4):1089-1092.
10. 10. Rourke KF, Welk B, Kodama R et al. Canadian Urological Association guideline on male urethral stricture. Can Urol Assoc J. 2020;14(10):305-316.
11. 11. Wessells H, Angermeier KW, Sean Elliott S, Christopher M. Gonzalez CM et al. Male Urethral Stricture: American Urological Association Guideline. The J. of Urology. 2017;197(1):182-193.
12. 12. Farrell MR, Lawrenz CW, Levine LA. Internal urethrotomy with intralesional mitomycin C: an effective option for endoscopic management of recurrent bulbar and bulbomembranous urethral strictures. Urology. 2017;110:223-227.
13. 13. Noureldin YA, Abdallah Fathy A, Ahmed S et al. Intralesional injection of mitomycin C following internal urethrotomy of de novo bulbar urethral stricture:New experience using a novel adjustable-tip needle. Arab journal of urology. 2021;19(4):473-479.
14. 14. Kovalenko IV, Onufrovych OK, Melnyk OV, Korchynska OS, Vorobets NM, Vorobets ZD. Effect of fluoroquinolones on the activity of the glutathione system in the peripheral blood lymphocytes. Experimental and Clinical Physiology and Biochemistry. 2019;3(87):23-9.
15. 15. Rjiba-Touati K, Ayed-Boussema I, Guedri Y et al. Effect of recombinant human erythropoietin on mitomycin C-induced oxidative stress and genotoxicity in rat kidney and heart tissues. Hum Exp Toxicol. 2016;35(1):53-62.
16. 16. Rjiba-Touati K, Ayed-Boussema I, Guedri Y et al. Heated naringin mitigate the genotoxicity effect of Mitomycin C in BALB/c mice through enhancing the antioxidant status. Biomedicine & Pharmacotherapy. 2018;97:1417-1423.
17. 17. Якубець ОЯ, Воробець ДЗ, Воробець ЗД, Гжегоцький МР. Антиоксидантний статус лімфоцитів крові здорових жінок різних вікових груп і хворих на рак яєчника. Вісник проблем біології та медицини. 2016;1(2):132-135.
18. 18. Barreta G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. Oncology. 2012;10:137-141.
19. 19. Naher ZU, Biswas SK, Mollah FH, Ali M, Arslan MI. Role of glutathione in male infertility. Bangladesh J Med Biochem. 2011;4(2):20-2.5
20. 20. Carlberg I, Mannervik B. Glutathione reductase. Methods in Enzymology. 1985; 113:484-490.
21. 21. Vorobets Z, Kimakovich O. Effect of proton pump blocker on enzyme activity of glutathione antioxidant system of the peripheral blood lymphocytes. Annales Universitatis Mariae-Sklodowska. 2006. 19(1): 131-134.
22. 22. Belikov AV, Schraven B, Simeoni L. T cells and reactive oxygen species. Journal of Biomedical Science. 2015;22:85-89.
23. 23. Тимирбулатов СА, Селезнев ЕИ. Метод повышения интенсивности свободнорадикального окисления липидсодержащих компонентов крови и его диагностическое значение. Лаб. дело. 1988;4:209-211.
24. 24. Fafula RV, Paranyak NM, Besedina AS, DZ, Iefremova UP, Onufrovych OK, Vorobets ZD. Biological significance of glutathione S-transferases in human sperm cells. J of Human Reproductive Sciences. 2019;12(1):24-28.
25. 25. Gautam N, Das S, Mahapatra SK et al. Age associated oxidative damage in lymphocytes. Oxid Med Cell Longev. 2010; 3(4): 275-282.
26. 26. Siddique YH, Ara G, Afzal M. Estimation of lipid peroxidation induced by hydrogen peroxide in cultured human lymphocytes. Dose Response. 2012;10(1):1-10.
27. 27. Лаповець Л, Луцик Б. Лабораторна імунологія. К.: Арал; 2004. 173 c.
28. 28. Фафула РВ, Єфремова УР, Мельник ОВ, Воробець ЗД, Кулачковський ОР. Методологічний підхід до вивчення ензиматичного спектру лімфоцитів при патологічних станах з використанням детергента сапоніну (ультраструктурне дослідження). Вісник проблем біології та медицини. 2012;4(96):163-166.